I am Acting Director and an Associate Professor at the Centre for the Business and Economics of Health at The University of Queensland. I lead Health Technology Assessment for the Centre, which involves the economic evaluation of health interventions. I have pioneered the application of Value of Information analysis as an innovative approach to ensure clinical trials are efficiently designed and prioritised to maximise return on investment.

I have extensive experience working with key stakeholders including consumers, clinicians, decision makers and researchers. I have led several projects for the Department of Health and other leading organisations to promote the safe, effective, and cost-effective use of health interventions in multiple settings and populations. I currently co-lead The University of Queensland Evaluation Services Team (QUEST), a group of researchers who provide evidence-based recommendations to the Commonwealth Pharmaceutical Benefits Advisory Committee regarding medicines on the Pharmaceutical Benefits Scheme. I am Chair of the Clinical Oncology Society of Australia's (COSA)-Epidemiology Group, the Australian Clinical Trials Alliance (ACTA)-Research Prioritisation Group and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)-Oncology Group. I am an Associate Editor for Value in Health, and an Editorial Board Member for Medical Decision Making and PharmacoEconomics-open journals.